Effects of Platelet-Activating Factor, Tumor Necrosis Factor, and Interleukin-1α on the Expression of Apolipoprotein M in HepG2 Cells
Authors:
- 1 April 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 292 (4) , 944-950
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Apolipoprotein DBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- High-density lipoprotein metabolism: Molecular targets for new therapies for atherosclerosisCurrent Atherosclerosis Reports, 2000
- A Novel Human Apolipoprotein (apoM)Journal of Biological Chemistry, 1999
- Apolipoprotein L, a New Human High Density Lipoprotein Apolipoprotein Expressed by the PancreasJournal of Biological Chemistry, 1997
- The J. David Gladstone InstitutesMolecular Medicine, 1997
- 2 Lipoproteins and atherosclerosisBailliere's Clinical Endocrinology and Metabolism, 1987
- 5 High-density lipoprotein: A major risk factor for coronary atherosclerosisBailliere's Clinical Endocrinology and Metabolism, 1987
- Chemical and biochemical aspects of platelet activating factor: A novel class of acetylated ether‐linked choline‐phospholipidsMedicinal Research Reviews, 1985
- Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasmaBiochemistry, 1982
- Cellular and Molecular Biology of Lipoprotein Metabolism in AtherosclerosisDiabetes, 1981